Small but Important Differences Seen Between Rosuvastatin, Atorvastatin
Rosuvastatin tied to cardiovascular and mortality benefits but also higher risk for type 2 diabetes
ASN: Hypertension Most Common Cardiovascular Comorbidity Seen With Dialysis
The next most common conditions included atherosclerotic heart disease and congestive heart failure
Exercise Cuts Dependence in Those With Alcohol Use Disorder
Additional benefits include significant improvement in the physical and mental states of people with alcohol use disorder
Causal Relationship Seen Between GERD and Hypertension
Authors call for future research to examine implications of GERD detection, management for the prevention and treatment of hypertension
Clinicians Often Fail to Rescue Women With Complications After High-Risk Surgery
Findings seen despite similar rates of serious complications to male patients
Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries
Authors say clinicians should evaluate trade-offs between pharmaceutical and surgical management of obesity
Many Seniors at Risk for Financial Precarity From Cost of Hospital Stay
Financial precarity more prevalent among Black and Hispanic versus White, those with less versus more than high school education
2010 to 2023 Saw Increase in GLP-1 RA, SGLT2 Inhibitor Use in Type 1...
Greatest increase in SGLT2 inhibitor use seen in subgroups with cardiovascular disease; greatest increase in GLP-1 RA for those with obesity
ASN: Empagliflozin Offers Lasting Cardiorenal Benefit in CKD Patients
Empagliflozin offers cardiorenal benefits for up to 12 months after discontinuation among CKD patients at risk for progression
Clinical Practice Guidelines Updated for Primary Prevention of Stroke
Recommendations include screening for and addressing adverse social determinants of health
